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Summary
 
We have examined the question of whether there is an additional checkpoint in T cell develop-
ment that regulates T cell receptor (TCR)-
 
b
 
 expression in CD25
 
1
 
44
 
2
 
 thymocytes by mecha-
nisms that are independent of the pre-TCR. Our analysis in various mutant mice indicates that all
changes in cytoplasmic TCR-
 
b
 
 expression can be accounted for by pre-TCR–dependent signal
mediation, putting into question the function of a putative pro-TCR.
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S
 
everal years ago, it was found that on the surface of im-
mature T cells CD3
 
e
 
 could be expressed in the apparent
absence of TCR chains for antigen, and that signals could
be transduced by cross-linking this complex with CD3 an-
tibodies (1–3). Since then, it has been discussed whether
CD3
 
e
 
 surface expression in apparent association with cal-
nexin (4) represents a biological accident without implica-
tion for physiological T cell maturation (5), or whether it is
perhaps indicative of a pro-TCR complex that controls de-
velopment. This would represent yet another checkpoint,
in addition to those controlled by the pre-TCR (6) and the
 
a
 
/
 
b 
 
TCR (7). In fact, it was recently argued that the second
possibility was likely to be correct, since impaired signal
transduction in p56
 
lck
 
 and CD3
 
z
 
-deficient mice appeared to
be associated with reduced expression of productively rear-
ranged TCR-
 
b
 
 genes (8, 9). However, it could not be ex-
 
cluded from these studies that the deficiency in TCR-
 
b
 
gene expression was dependent on defective signaling by the
pre-TCR or the 
 
a
 
/
 
b
 
 TCR, since the analysis included
thymocyte subsets whose generation depended either on the
pre-TCR (some CD25
 
1
 
44
 
2
 
 cells [10]) or the 
 
a
 
/
 
b
 
 TCR
(CD25
 
2
 
44
 
1
 
 NK T cells [11]). For that reason, we have an-
alyzed TCR-
 
b
 
 expression by intracellular staining in a vari-
ety of mutant mouse strains in small CD25
 
1
 
44
 
2
 
 cells that are
independent of the pre-TCR and the 
 
a
 
/
 
b 
 
TCR. Our data
indicate that all differences that exist in TCR-
 
b
 
 gene ex-
pression among various mouse strains can be attributed to
signal transduction by the pre-TCR, since small CD25
 
1
 
44
 
2
 
thymocytes of pre-TCR 
 
a
 
 chain–deficient mice exhibited
the same phenotype observed in CD3-deficient mice, thus
arguing against a distinct checkpoint in development con-
trolled by the CD3 complex in the absence of the pre-TCR.
 
Materials and Methods
 
Animals.
 
CD3
 
e
 
2
 
/
 
2
 
, pT
 
a
 
2
 
/
 
2
 
, and 
 
g
 
c
 
2
 
/
 
2
 
 mice have been de-
scribed (6, 12, 13) and were bred in the specific pathogen–free
animal facilities of the Necker Institute, Paris. C57BL/6 and
 
Rag2
 
2
 
/
 
2
 
 mice were purchased from Iffa Credo. Animals were ana-
lyzed at 6–8 wk of age. Animal care was in accordance with insti-
tutional guidelines.
 
Antibodies and Immunofluorescence Analysis.
 
The following mAbs
were used: CD25 (PC-61) conjugated to FITC, CD44 (Pgp-1)–PE,
CD25-PE, CD4 (L3T4)-CyChrome, CD8 (Ly-2)–CyChrome
(PharMingen), and anti-pan TCR-
 
b
 
 (H57-597). Biotinylated mAbs
were revealed with either streptavidin-PE (Southern Biotech-
nology) or streptavidin-allophycocyanin (APC; Molecular Probes
Europe). Cells were stained in microtiter plates (10
 
6
 
 cells/well in
50 
 
m
 
l) using combinations of directly conjugated mAbs. Simulta-
neous four-color cell analyses were performed on a FACSCali-
bur™ flow cytometer (Becton Dickinson). Dead cells were ex-
cluded by gating based on forward and side scatter characteristics.
 
Intracellular Staining for TCR-
 
b
 
 Chains.
 
Thymocytes were en-
 
riched for the CD4
 
2
 
8
 
2
 
 subset by negative depletion of CD4/
CD8
 
1
 
 cells using Dynabeads (Dynal). For extracellular/intracellu-
lar double staining, cells were first incubated with culture superna-
tant of mAb 2.4G2 to block FcRII/III receptors. Cells were then
stained with FITC-conjugated anti-CD25, PE-conjugated anti-
CD44, and CyChrome-conjugated anti-CD4 and anti-CD8 at
optimal concentration. After washing in PBS, cells were fixed in
PBS plus 0.5% paraformaldehyde for 15 min at room tempera-
ture, followed by two washing steps in PBS. Cells were then per- 
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meabilized in 0.5% saponin for 10 min at room temperature and
washed in PBS. Intracellular staining with biotinylated anti–pan
TCR-
 
b
 
 (H57-597) diluted in PBS/2% FCS plus 0.5% saponin
was performed for 30 min at 4
 
8
 
C, washed twice in PBS/2% FCS,
and revealed for 30 min at 4
 
8
 
C by streptavidin-APC diluted in
PBS/2% FCS plus 0.5% saponin. Cytoplasmic staining was fol-
lowed by two washing steps in PBS and 15 min on a rocking
platform in PBS/2% FCS plus 0.5% saponin on ice. Finally, cells
were washed in PBS/2% FCS.
 
Results and Discussion
 
Intracellular TCR-
 
b
 
 Gene Expression in CD4
 
2
 
8
 
2
 
 Subsets of
Thymocytes.
 
We have analyzed thymocytes from wild-
type, 
 
g
 
c
 
2
 
/
 
2
 
 (12), pT
 
a
 
2
 
/
 
2
 
 (6), CD3
 
e
 
2
 
/
 
2
 
 (13), and Rag2
 
2
 
/
 
2
 
mice (14) in order to analyze the effect of each mutation on
TCR-
 
b
 
 gene expression in small CD25
 
1
 
44
 
2
 
 cells. The
subset distribution among CD4
 
2
 
8
 
2
 
 cells according to CD44
and CD25 expression is shown in Fig. 1. Wild-type and
 
g
 
c
 
2
 
/
 
2
 
 mice exhibit a similar phenotype except for an ele-
vated proportion of CD44
 
1
 
25
 
1
 
 cells in the latter due to a
partial block at this stage of development in 
 
g
 
c
 
2
 
/
 
2
 
 mice.
pT
 
a
 
2
 
/
 
2
 
 mice look similar to CD3
 
e
 
2
 
/
 
2
 
 and Rag2
 
2
 
/
 
2
 
 mice,
but due to their incomplete block at the CD44
 
2
 
25
 
1
 
 stage
of development, contain more CD44
 
2
 
25
 
2
 
 cells than the
latter two strains. Of these, some 70% are 
 
g
 
/
 
d
 
 T cells (6).
When intracellular TCR-
 
b
 
 expression versus CD25 ex-
pression was analyzed in all CD4
 
2
 
8
 
2
 
 cells, it became clear
that wild-type and 
 
g
 
c
 
2
 
/
 
2
 
 thymocytes express TCR 
 
b
 
 chains
in the majority of cells, but 
 
g
 
c
 
2
 
/
 
2
 
 thymocytes less so be-
cause of an early partial block before TCR-
 
b
 
 rearrangement
at the CD44
 
1
 
25
 
1
 
 stage (12). In these two strains, most
TCR-
 
b
 
 expression was present in CD252 cells. In con-
trast, in pTa2/2 and CD3e2/2 mice, most TCR-b expres-
sion was found in CD251 cells, although less completely so
in pTa2/2 mice because of a partial developmental block at
the CD251442 stage resulting in a population of CD252442
cells, of which up to 70% are g/d T cells. Of these g/d T
cells, up to 25% expressed cytoplasmic TCR b chains (15),
which accounts for the cytoplasmic TCR-b staining in the
CD252 cells in pTa2/2 mice (Fig. 2 A). There is naturally
no TCR-b expression in Rag22/2 mice (Fig. 2). However,
this picture changed, to some extent, when the analysis was
performed on smaller cells where the proportion of TCR-b1
cells among CD251 cells was significantly decreased in
wild-type and gc2/2 mice but not at all or only marginally
in pTa2/2 and CD3e2/2 mice (Fig. 2 B). What is also ap-
parent in Fig. 2 B is that the proportion of TCR-b1 cells
among small CD251 cells is significantly smaller in wild-
type and gc2/2 mice, while it is larger in pTa2/2 and
CD3e2/2 mice. This is due to the fact that in CD251 cells
from pTa2/2 and CD3e2/2 mice, TCR-b rearrangement
proceeds further than in normal mice (16, 17). It is also
clear from Fig. 2, A and B, that CD251 cells in wild-type
and gc2/2 mice express on average higher TCR-b levels
than CD251 cells from pTa2/2 and CD3e2/2 mice, and
that with regard to this parameter there is no significant dif-
ference between CD251 cells from pTa2/2 and CD3e2/2
cells. Actually, there is a continuous spectrum of TCR-b
expression rather than a discrete peak, which would be ex-
pected from a population of cells that undergoes TCR-b
rearrangement and begins to express productive genes.
Nevertheless, there is no doubt that the staining is specific,
since there is no staining in the same population of cells in
Rag22/2 mice (Fig. 2), and also because an irrelevant con-
trol antibody of the same Ig class does not stain in all differ-
ent mouse strains (data not shown). Thus, all differences
that exist between wild-type and CD3e2/2 mice with re-
gard to TCR-b expression in CD251 cells can be attrib-
uted to defective signaling by the pre-TCR rather than to
an independent control of TCR-b expression by the CD3
complex alone.
We have focused on TCR-b expression in small
CD251442 cells only, and it is clear that in this thymocyte
subset the proportion of cells expressing TCR-b in their
cytoplasm is much smaller than in a population that con-
tains CD251 as well as CD441 cells, due to the presence of
CD441 NK T cells in the latter population that express a/b
TCRs on their cell surface (11) and were included in pre-
vious analyses (8). The NK T cell population is likely to be
absent in lck2/2, z2/2 mice because it is a highly selected
population that requires signaling through the CD3 com-
plex. Thus, this population would depend on signaling by
the a/b TCR rather than just by p56lck and z chains, as
Figure 1. Representative FACS® staining profile of CD4282 thy-
mocytes from C57BL/6 (WT), gc2/2, pTa2/2, CD3e2/2, and Rag22/2
mice. Thymocytes were double stained for CD25 and CD44 surface anti-
gens as described. The percentages of cells in each quadrant are indicated.143 Aifantis et al. Brief Definitive Report
suggested by Wurch et al. (8). The NK T cell population,
for reasons so far unknown, is absent in the pTa2/2 mice
(18). Moreover, the CD251442 subset contains a popula-
tion of pre-TCR–dependent large cells that apparently was
included in previous studies (8). If one eliminates these
populations of cells from analysis, one nevertheless finds
differences in the proportion of CD251 cells expressing
TCR-b, as well as in the level of TCR-b per cell between
wild-type and CD3e2/2 mice: in the former, fewer CD251
cells express TCR-b and at higher levels compared with
CD3e2/2 mice. However, the same difference is also noted
between wild-type and pTa2/2 mice, indicating that this
difference is dependent on signal transduction by the pre-
TCR rather than signal transduction by p56lck and CD3z in
the absence of the pre-TCR, as suggested previously (8, 9).
In summary, analysis of TCR-b expression in CD251 cells
argues against the notion that levels of TCR-b are upregu-
lated by a pro-TCR rather than the pre-TCR. Rather, they
demonstrate that it is the pre-TCR complex in which CD3
signal transducing molecules exert their biological function
for the first time in the development of a/b lineage cells.
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